Lipid phosphatases as drug discovery targets for type 2 diabetes (original) (raw)

• Amos, A. F., McCarty, D. J. & Zimmet, P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 14 (Suppl. 5), S1–S85 (1997).
  PubMed Google Scholar
• Pessin, J. E. & Saltiel, A. R. Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 106, 165–169 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Shulman, G. I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171–176 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Saltiel, A. R. & Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799–806 (2001).
  Article CAS PubMed Google Scholar
• Patti, M. E. & Kahn, C. R. The insulin receptor-a critical link in glucose homeostasis and insulin action. J. Basic Clin. Physiol. Pharmacol. 9, 89–109 (1998).
  Article CAS PubMed Google Scholar
• White, M. F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182, 3–11 (1998).
  Article CAS PubMed Google Scholar
• Sun, X. J. et al. Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173–177 (1995).
  Article CAS PubMed Google Scholar
• Lavan, B. E. et al. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272, 21403–21407 (1997).
  Article CAS PubMed Google Scholar
• Lavan, B. E., Lane, W. S. & Lienhard, G. E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272, 11439–11443 (1997).
  Article CAS PubMed Google Scholar
• Sasaoka, T. et al. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J. Biol. Chem. 269, 13689–13694 (1994).
  Article CAS PubMed Google Scholar
• Liu, J., Kimura, A., Baumann, C. A. & Saltiel, A. R. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol. Cell. Biol. 22, 3599–3609 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ribon, V. & Saltiel, A. R. Insulin stimulates tyrosine phos-phorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem. J. 324, 839–845 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K. & Wong, A. J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560–564 (1996).
  Article CAS PubMed Google Scholar
• Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
  Article CAS PubMed Google Scholar
• Tamemoto, H. et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182–186 (1994).
  Article CAS PubMed Google Scholar
• Araki, E. et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186–190 (1994).
  Article CAS PubMed Google Scholar
• Bruning, J. C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561–572 (1997).
  Article CAS PubMed Google Scholar
• Kido, Y., Nakae, J. & Accili, D. Clinical review 125: The insulin receptor and its cellular targets. J. Clin. Endocrinol. Metab. 86, 972–979 (2001).
  CAS PubMed Google Scholar
• Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. & Ui, M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568–3573 (1994). One of the earliest studies to suggest a crucial role for insulin-stimulated PI3K activity in producing the metabolic responses to the hormone. Subsequent investigations have corroborated and expanded on these initial observations, leading to the recognition that PI3K activation has a major role in most metabolic responses to insulin.
  Article CAS PubMed Google Scholar
• Cheatham, B. et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14, 4902–4911 (1994). While providing independent evidence for a connection between insulin-stimulated PI3K activity and metabolic responses, divergence in insulin signalling was proposed whereby PI3K does not significantly affect MAPK phosphorylation. Such data supports the existence of divergent pathways promoting the metabolic versus mitogenic responses to insulin.
  CAS PubMed PubMed Central Google Scholar
• Evans, J. L., Honer, C. M., Womelsdorf, B. E., Kaplan, E. L. & Bell, P. A. The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. Cell Signal. 7, 365–376 (1995).
  Article CAS PubMed Google Scholar
• Quon, M. J. et al. Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol. Cell. Biol. 15, 5403–5411 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Martin, S. S. et al. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 271, 17605–17608 (1996).
  Article CAS PubMed Google Scholar
• Vanhaesebroeck, B. & Alessi, D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561–576 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mora, A., Komander, D., van Aalten, D. M. & Alessi, D. R. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15, 161–170 (2004).
  Article CAS PubMed Google Scholar
• Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005).
  Article CAS PubMed Google Scholar
• Niswender, K. D. et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52, 227–231 (2003).
  Article CAS PubMed Google Scholar
• Carvalheira, J. B. et al. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 46, 1629–1640 (2003).
  Article CAS PubMed Google Scholar
• Niswender, K. D. et al. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413, 794–795 (2001).
  Article CAS PubMed Google Scholar
• Zhao, A. Z., Huan, J. N., Gupta, S., Pal, R. & Sahu, A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nature Neurosci. 5, 727–728 (2002).
  Article CAS PubMed Google Scholar
• Rahmouni, K., Haynes, W. G., Morgan, D. A. & Mark, A. L. Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 41, 763–767 (2003).
  Article CAS PubMed Google Scholar
• Goberdhan, D. C. & Wilson, C. PTEN: tumour suppressor, multifunctional growth regulator and more. Hum. Mol. Genet. 12, R239–R248 (2003).
  Article CAS PubMed Google Scholar
• Leslie, N. R. & Downes, C. P. PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1–11 (2004). Review of PTEN biology, including its role in signal transduction and mechanisms believed to modulate PTEN activity level. Discussion of the compelling evidence for PTEN as an important tumour suppressor powerfully conveys the significance of this issue to any PTEN inhibitor drug discovery effort.
  Article CAS PubMed PubMed Central Google Scholar
• Ogg, S. & Ruvkun, G. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2, 887–893 (1998). Important observation that precipitated numerous investigations exploring the capacity of this lipid phosphatase (PTEN) to regulate in vivo insulin signalling.
  Article CAS PubMed Google Scholar
• Goberdhan, D. C., Paricio, N., Goodman, E. C., Mlodzik, M. & Wilson, C. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13, 3244–3258 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Nakashima, N., Sharma, P. M., Imamura, T., Bookstein, R. & Olefsky, J. M. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 275, 12889–12895 (2000).
  Article CAS PubMed Google Scholar
• Ono, H. et al. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Mol. Endocrinol. 15, 1411–1422 (2001).
  Article CAS PubMed Google Scholar
• Mosser, V. A., Li, Y. & Quon, M. J. PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions. Biochem. Biophys. Res. Commun. 288, 1011–1017 (2001).
  Article CAS PubMed Google Scholar
• Tang, X., Powelka, A. M., Soriano, N. A., Czech, M. P. & Guilherme, A. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem. 280, 22523–22529 (2005).
  Article CAS PubMed Google Scholar
• Seo, J. H., Ahn, Y., Lee, S. R., Yeol Yeo, C. & Chung Hur, K. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell 16, 348–357 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Butler, M. et al. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51, 1028–1034 (2002). First evidence that in vivo suppression of PTEN expression might enhance insulin signalling and provide efficacy against type 2 diabetes.
  Article CAS PubMed Google Scholar
• Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–1783 (2004). Dramatic evidence that severe adverse effects of PTEN inhibition in the liver would likely limit the usefulness of any PTEN inhibitor hitting that important insulin-sensitive tissue.
  Article CAS PubMed PubMed Central Google Scholar
• Stiles, B. et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc. Natl Acad. Sci. USA 101, 2082–2087 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wijesekara, N. et al. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25, 1135–1145 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kurlawalla-Martinez, C. et al. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 25, 2498–2510 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lo, Y. T., Tsao, C. J., Liu, I. M., Liou, S. S. & Cheng, J. T. Increase of PTEN gene expression in insulin resistance. Horm. Metab. Res. 36, 662–666 (2004).
  Article CAS PubMed Google Scholar
• Hansen, L. et al. Studies of variability in the PTEN gene among Danish caucasian patients with Type II diabetes mellitus. Diabetologia 44, 237–240 (2001).
  Article CAS PubMed Google Scholar
• Ishihara, H. et al. Association of the polymorphisms in the 5′-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett. 554, 450–454 (2003).
  Article CAS PubMed Google Scholar
• Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y. & Lucas, D. M. Structure, function, and biology of SHIP proteins. Genes Dev. 14, 505–520 (2000).
  Article CAS PubMed Google Scholar
• Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. & Erneux, C. Identification of a second SH2-domain-containing protein closely related to the phosphatidyl-inositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239, 697–700 (1997).
  Article CAS PubMed Google Scholar
• Backers, K., Blero, D., Paternotte, N., Zhang, J. & Erneux, C. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv. Enzyme Regul. 43, 15–28 (2003).
  Article CAS PubMed Google Scholar
• Chi, Y. et al. Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe Synaptojanin and SHIP2. J. Biol. Chem. 279, 44987–44995 (2004).
  Article CAS PubMed Google Scholar
• Kalesnikoff, J. et al. The role of SHIP in cytokine-induced signaling. Rev. Physiol. Biochem. Pharmacol. 149, 87–103 (2003).
  Article CAS PubMed Google Scholar
• Sleeman, M. W. et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nature Med. 11, 199–205 (2005). Second report of the experimental deletion of the Ship2 gene in mice. Anti-obesity phenotype of these Ship2 knockout mice has prompted significant discussion of peripheral and/or central mechanisms by which SHIP2 might have such a profound effect on energy metabolism.
  Article CAS PubMed Google Scholar
• Ishihara, H. et al. Membrane localization of Src homology 2-containing inositol 5′-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Mol. Endocrinol. 16, 2371–2381 (2002).
  Article CAS PubMed Google Scholar
• Dyson, J. M. et al. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell. Biol. 155, 1065–1079 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Damen, J. E., Ware, M. D., Kalesnikoff, J., Hughes, M. R. & Krystal, G. SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation. Blood 97, 1343–1351 (2001).
  Article CAS PubMed Google Scholar
• Liu, L. et al. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J. Biol. Chem. 272, 8983–8988 (1997).
  Article CAS PubMed Google Scholar
• Dyson, J. M. et al. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Int. J. Biochem. Cell Biol. 37, 2260–2265 (2005).
  Article CAS PubMed Google Scholar
• Habib, T., Hejna, J. A., Moses, R. E. & Decker, S. J. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J. Biol. Chem. 273, 18605–18609 (1998).
  Article CAS PubMed Google Scholar
• Ishihara, H. et al. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem. Biophys. Res. Commun. 260, 265–272 (1999).
  Article CAS PubMed Google Scholar
• Blero, D. et al. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem. Biophys. Res. Commun. 282, 839–843 (2001).
  Article CAS PubMed Google Scholar
• Wada, T. et al. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21, 1633–1646 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Sasaoka, T. et al. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J. Biol. Chem. 279, 14835–14843 (2004).
  Article CAS PubMed Google Scholar
• Wada, T. et al. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis. Endocrinology 140, 4585–4594 (1999).
  Article CAS PubMed Google Scholar
• Sharma, P. M., Son, H. S., Ugi, S., Ricketts, W. & Olefsky, J. M. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes. Mol. Endocrinol. 19, 421–430 (2005).
  Article CAS PubMed Google Scholar
• Sasaoka, T. et al. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44, 1258–1267 (2001).
  Article CAS PubMed Google Scholar
• Murakami, S. et al. Impact of Src homology 2-containing inositol 5′-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids. Endocrinology 145, 3215–3223 (2004).
  Article CAS PubMed Google Scholar
• Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728–1731 (2001).
  Article CAS PubMed Google Scholar
• Bae, S. S., Cho, H., Mu, J. & Birnbaum, M. J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278, 49530–49536 (2003).
  Article CAS PubMed Google Scholar
• Garofalo, R. S. et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J. Clin. Invest. 112, 197–208 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Sasaoka, T. et al. Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes. Diabetologia 48, 336–344 (2005).
  Article CAS PubMed Google Scholar
• Clement, S. et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92–97 (2001). First report of the experimental deletion of the Ship2 gene in mice. Although the subsequent discovery of the accidental co-disruption of a second gene ( Phox2a ) has introduced a complicating factor, this is still the first reported evidence for SHIP2 regulation of insulin signaling in vivo.
  Article CAS PubMed Google Scholar
• Clement, S. et al. corrigenda: The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 431, 878 (2004).
  Article CAS Google Scholar
• Manning, B. D. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J. Cell. Biol. 167, 399–403 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Chiang, S. H. et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410, 944–948 (2001).
  Article CAS PubMed Google Scholar
• Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544–1548 (1999).
  Article CAS PubMed Google Scholar
• Klaman, L. D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20, 5479–5489 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Plum, L., Schubert, M. & Bruning, J. C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16, 59–65 (2005). Concise discussion of the biology of centrally-acting insulin and its subsequent impact on whole-body energy balance, peripheral glucose homeostasis, reproduction and a potentially positive role in cognitive function and protection from neurodegenerative disease. The important role for insulin stimulation of PI3K in these activities is discussed.
  Article CAS PubMed Google Scholar
• Niswender, K. D. & Schwartz, M. W. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol. 24, 1–10 (2003).
  Article CAS PubMed Google Scholar
• Niswender, K. D., Baskin, D. G. & Schwartz, M. W. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol. Metab. 15, 362–369 (2004).
  Article CAS PubMed Google Scholar
• Gerozissis, K. Brain insulin and feeding: a bi-directional communication. Eur J Pharmacol 490, 59–70 (2004).
  Article CAS PubMed Google Scholar
• Porte, D., Jr., Baskin, D. G. & Schwartz, M. W. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54, 1264–1276 (2005). Compelling and comprehensive review of the profound impact insulin signaling in the brain has on a wide range of integrated metabolic activities, including the regulation of food intake, energy expenditure, glucose homeostasis, and reproduction. In addition, evidence for cross-talk with leptin (including at the level of PI3K activation) and relevance to the known linkage between obesity and diabetes are thoughtfully explored.
  Article CAS PubMed Google Scholar
• Burks, D. J. et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377–382 (2000).
  Article CAS PubMed Google Scholar
• Masaki, T. et al. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes. Res. 12, 878–885 (2004).
  Article CAS PubMed Google Scholar
• Bruning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000).
  Article CAS PubMed Google Scholar
• Obici, S., Feng, Z., Karkanias, G., Baskin, D. G. & Rossetti, L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neurosci. 5, 566–572 (2002).
  Article CAS PubMed Google Scholar
• Xu, A. W. et al. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115, 951–958 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Carvalheira, J. B. et al. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes. Res. 13, 48–57 (2005).
  Article CAS PubMed Google Scholar
• Rahmouni, K. et al. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J. Clin. Invest. 114, 652–658 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Fisher, S. J., Bruning, J. C., Lannon, S. & Kahn, C. R. Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes 54, 1447–1451 (2005).
  Article CAS PubMed Google Scholar
• Mirshamsi, S. et al. Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation. BMC Neurosci. 5, 54 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Pocai, A. et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434, 1026–1031 (2005).
  Article CAS PubMed Google Scholar
• Clegg, D. J. et al. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R981–R986 (2005).
  Article CAS PubMed Google Scholar
• De Souza, C. T. et al. Consumption of a fat-rich diet activates a pro-inflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199 (2005).
  Article CAS PubMed Google Scholar
• Lin, S., Thomas, T. C., Storlien, L. H. & Huang, X. F. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int. J. Obes. Relat. Metab. Disord. 24, 639–646 (2000).
  Article CAS PubMed Google Scholar
• Lin, L., Martin, R., Schaffhauser, A. O. & York, D. A. Acute changes in the response to peripheral leptin with alteration in the diet composition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R504– R509 (2001).
  Article CAS PubMed Google Scholar
• Wilsey, J., Zolotukhin, S., Prima, V. & Scarpace, P. J. Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R1011– R1020 (2003).
  Article CAS PubMed Google Scholar
• Lu, H. et al. Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res. Bull. 47, 331–335 (1998).
  Article CAS PubMed Google Scholar
• Zabolotny, J. M. et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2, 489–95 (2002).
  Article CAS PubMed Google Scholar
• Cheng, A. et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2, 497–503 (2002).
  Article CAS PubMed Google Scholar
• Schulingkamp, R. J., Pagano, T. C., Hung, D. & Raffa, R. B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24, 855–872 (2000).
  Article CAS PubMed Google Scholar
• Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–71 (1995).
  Article CAS PubMed Google Scholar
• Kurrimbux, D., Gaffen, Z., Farrell, C. L., Martin, D. & Thomas, S. A. The involvement of the blood-brain and the blood-cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain. Neuroscience 123, 527–536 (2004).
  Article CAS PubMed Google Scholar
• Muraille, E. et al. The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience 105, 1019–1030 (2001).
  Article CAS PubMed Google Scholar
• Hori, H. et al. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51, 2387–2394 (2002).
  Article CAS PubMed Google Scholar
• Fukui, K. et al. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54, 1958–1967 (2005).
  Article CAS PubMed Google Scholar
• Marion, E. et al. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51, 2012–2017 (2002).
  Article CAS PubMed Google Scholar
• Kaisaki, P. J. et al. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 53, 1900–1904 (2004).
  Article CAS PubMed Google Scholar
• Kagawa, S. et al. Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90, 2911–2919 (2005).
  Article CAS PubMed Google Scholar
• Prasad, N., Topping, R. S. & Decker, S. J. SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol. Cell. Biol. 21, 1416–1428 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Koch, A., Mancini, A., El Bounkari, O. & Tamura, T. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene 24, 3436–3447 (2005).
  Article CAS PubMed Google Scholar
• Giuriato, S. et al. SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem. Biophys. Res. Commun. 296, 106–110 (2002).
  Article CAS PubMed Google Scholar
• Taylor, V. et al. 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20, 6860–6871 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Blero, D. et al. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts. FEBS J. 272, 2512–2522 (2005).
  Article CAS PubMed Google Scholar
• Choi, Y. et al. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21, 5289–5300 (2002).
  Article CAS PubMed Google Scholar
• Wisniewski, D. et al. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93, 2707–2720 (1999).
  Article CAS PubMed Google Scholar
• Helgason, C. D. et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610–1620 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Tsujishita, Y., Guo, S., Stolz, L. E., York, J. D. & Hurley, J. H. Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase. Cell 105, 379–389 (2001).
  Article CAS PubMed Google Scholar
• Fisher, D. K. & Higgins, T. J. A sensitive, high-volume, colorimetric assay for protein phosphatases. Pharm. Res. 11, 759–763 (1994).
  Article CAS PubMed Google Scholar
• Maehama, T., Taylor, G. S., Slama, J. T. & Dixon, J. E. A sensitive assay for phosphoinositide phosphatases. Anal. Biochem. 279, 248–250 (2000).
  Article CAS PubMed Google Scholar
• Drees, B. E. et al. Competitive fluorescence polarization assays for the detection of phosphoinositide kinase and phosphatase activity. Comb. Chem. High Throughput Screen. 6, 321–330 (2003).
  Article CAS PubMed Google Scholar
• Gray, A., Olsson, H., Batty, I. H., Priganica, L. & Peter Downes, C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313, 234–245 (2003).
  Article CAS PubMed Google Scholar
• Oatey, P. B. et al. Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes. Biochem. J. 344, 511–518 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, M., Ueda, Y., Takagi, T. & Umezawa, Y. Production of PtdInsP3 at endomembranes is triggered by receptor endocytosis. Nature Cell. Biol. 5, 1016–1022 (2003). One of several recent reports demonstrating novel approaches for the measurement of PtdIns(3,4,5)P 3 levels in biological samples. The FRET-based biosensor approach utilized in this study is noteworthy for the ability to continuously monitor PtdIns(3,4,5)P 3 levels in living cells and in specific subcellular compartments.
  Article CAS PubMed Google Scholar
• Tengholm, A., Teruel, M. N. & Meyer, T. Single cell imaging of PI3K activity and glucose transporter insertion into the plasma membrane by dual color evanescent wave microscopy. Sci STKE 2003, PL4 (2003).
  Article PubMed Google Scholar
• Niswender, K. D. et al. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J. Histochem. Cytochem. 51, 275–283 (2003).
  Article CAS PubMed Google Scholar
• Wiesmann, C. et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Struct. Mol. Biol. 11, 730–737 (2004).
  Article CAS Google Scholar
• Yang, L. et al. Synthesis of pelorol and analogues: activators of the inositol 5-phosphatase SHIP. Org. Lett. 7, 1073–1076 (2005).
  Article CAS PubMed Google Scholar